All News

In an ideal world, how would you hypothesize that technology might be able to solve all of your problems?

What is causing the suspicious MRI results?

An FDA committee has recommended approval of Gilead’s Descovy to reduce the risk of sexually acquired HIV infection in those at high risk of acquiring the virus.

An FDA committee voted 16 to 2 to recommended emitricitabine 200 mg and tenofovir alafenamide 25 mg tablets (Descovy, Gilead) for a HIV pre-exposure prophylaxis indication.

These new Guarded Luer Connectors are used to join two luer lock syringes or other luer lock devices.

As new pharmacists receive their exam results and enter the workforce, many are facing questions about their school experiences, career plans, further education plans, and the rising debt students face.

Galcanezumab-gnlm (Emgality, Eli Lilly) may be an effective option for patients who failed previous migraine preventive treatments.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

The phase 3 IMvigor130 study is the first to assess a cancer immunotherapy combination in previously untreated advanced bladder cancer.

High school students will explore pharmacy careers through activities such as extracting DNA from strawberries, and getting out of a pharmacy-themed escape room, during the upcoming Discover Pharmacy day camp, at Wilkes University.

By searching for hyperactive cell signals in primary effusion lymphoma, researchers were able to find a pathway that can be blocked to limit tumor growth.

Top news of the day from across the health care landscape.

Vizient, Inc. has released its July 2019 Drug Price Forecast, which projects that health systems can expect a 4.57% increase for pharmaceutical purchases made in 2020.

Pharmacy and public health associations have released statements following the recent shootings in California, Texas, and Ohio, and some are discussing what actions they can take to prevent further gun-related injury and death.

The conference will take place in conjunction with the 7th National Association of Specialty Pharmacy Annual Meeting & Expo.

Drug overdoses involving opioids have increased, and naloxone can be a life-saving drug to prevent deaths.

A study in the Bukoba municipality of Tanzania has suggested that scaling up HIV testing, improving linkages to HIV care, and strengthening retention of antiretroviral therapy interventions can help increase viral load suppression (VLS).

A regimen of afatinib as a first-line treatment followed by osimertinib in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer was found to significantly improve overall survival.

Identifying gene-pair relationships may help scientists understand why mutations in certain genes lead to cancer in certain tissues.

Top news of the day from across the health care landscape.

Officials with the FDA issued a statement to clarify data accuracy issues with recently-approved gene therapy Zolgensma (onasemnogene abeparvovec-xioi, AveXis), a product intended to treat spinal muscular atrophy (SMA) in children under 2 years old.

Officials with the FDA are assessing data accuracy issues related to Zolgensma, but have no major concerns about the spinal muscular atrophy treatment remaining on the market.

An analysis of previous studies of children and young adults with ADHD has quantified the extent to which stimulant treatment reduces the development of mood disorders, problems in school, conduct disorders, substance use disorders, and other problems.

The opioid epidemic has become widespread throughout the country, and it is considered a top public health priority.

Effective patient-provider communication is critical to the healing process and it begins the moment the patient makes contact with the staff and continues even after the patient fills his prescription at the pharmacy.

Research could lead to the development of new cancer treatments to stop tumor growth.

Top news of the day from across the health care landscape.